Abstract
Introduction Assessing the risk factors for and consequences of infection with SARS-CoV-2 during pregnancy is essential to guide clinical guidelines and care. Previous studies on the influence of SARS-CoV-2 infection in pregnancy have been among hospitalised patients, which may have exaggerated risk estimates of severe outcomes because all cases of SARS-CoV-2 infection in the pregnant population were not included. The objectives of this study were to identify risk factors for and outcomes after SARS-CoV-2 infection in pregnancy independent of severity of infection in a universally tested population, and to identify risk factors for and outcomes after severe infection requiring hospital admission.
Material and Methods This was a prospective population-based cohort study in Denmark using data from the Danish National Patient Register and Danish Microbiology Database and prospectively registered data from medical records. We included all pregnancies between March 1 and October 31, 2020 and compared women with a positive SARS-CoV-2 test during pregnancy to non-infected pregnant women. Cases of SARS-CoV-2 infection in pregnancy were both identified prospectively and through register linkage to secure that all cases were identified and that cases were pregnant during infection. Main outcome measures were pregnancy, delivery, maternal, and neonatal outcomes. Severe infection was defined as hospital admission due to COVID-19.
Results Among 82 682 pregnancies, 418 women had SARS-CoV-2 infection during pregnancy, corresponding to an incidence of 5.1 per 1000 pregnancies, 23 (5.5%) of which required hospital admission due to COVID-19. Risk factors for infection were asthma (OR 2.19 [1.41–3.41]) and being foreign born (OR 2.12 [1.70–2.64]). Risk factors for hospital admission due to COVID-19 included obesity (OR 2.74 [1.00–7.51]), smoking (OR 4.69 [1.58–13.90]), infection after gestational age (GA) 22 weeks (GA 22–27 weeks: OR 3.77 [1.16–12.29]; GA 28–36 weeks: OR 4.76 [1.60–14.12]) and having asthma (OR 4.53 [1.39–14.79]). We found no difference in any obstetric or neonatal outcomes.
Conclusions Only 1 in 20 women with SARS-CoV-2 infection during pregnancy require admission to hospital due to COVID-19. And severe outcomes of SARS-CoV-2 infection in pregnancy are rare.
Key Message Population based cohort study about SARS-CoV-2 infection during pregnancy. Asthma and foreign ethnicity were identified as risk factors for infection while obstetric outcomes did not change. Obesity, smoking, infection after GA 22, and asthma increased the risk of hospital admission.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by grants from the Danish Ministry of Higher Education and Science (Reg. no. 0237-00007B), The Region of Southern Denmark and Region Zealands shared fund for joint health research projects (Reg. no. A767) and The Nordic Federation of Societies of Obstetrics and Gynecology (NFOG). The funding sources had no influence on the study design, data collection and analysis, interpretation of data, preparation of the manuscript, or decision to submit the paper.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Danish Patient Safety Authority on the April 24, 2020 (reg. no. 31-1521-252), the regional Data Protection Agency in Region Zealand on the March 23, 2020 (reg. no. REG-022-2020), and the regional Data Protection Agency in Region of Southern Denmark on April 15, 2020 (reg. no. 20/17416).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data in the registry study cannot be shared by the authors but is available upon request from the Danish National Health Data Authority through their research service (https://sundhedsdatastyrelsen.dk/da/forskerservice). Data from the Danish COvid-19 in pregnancy Database (DCOD) database can be requested by contact to the first author.
Abbreviations
- BMI
- Body mass index
- CI
- Confidence interval
- COVID-19
- Coronavirus disease
- DCOD
- the Danish COVID-19 in pregnancy database
- DNPR
- The Danish National Patient Register
- EDD
- Estimated date of delivery
- GA
- Gestational age in completed weeks
- HR
- Hazard ratio
- ICU
- Intensive care unit
- IQR
- Interquartile range
- LMP
- Date of the first day of the last menstrual period
- MiBa
- Danish Microbiology Database
- NICU
- Neonatal intensive care unit
- OR
- Crude odds ratio
- PCR
- Polymerase chain reaction
- SARS-CoV-2
- Severe acute respiratory syndrome coronavirus 2
- W
- Weeks